The formulation of biopharmaceutical products.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Pharmaceutical science & technology today

• Publication date

  2000-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1461-5347(00)00248-0PMID 10754542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A CD strategy for the study of polypeptide folding/unfolding. A synthetic foot-and-mouth disease virus immunogenic peptide.

  2009cited by this paper
• Moisture-Induced Aggregation of Lyophilized Insulin

  2004cited by this paper
• Factors affecting short-term and long-term stabilities of proteins.

  2001cited by this paper
• Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies.

  2000cited by this paper
• PROTEIN AND PEPTIDE CHEMICAL AND PHYSICAL STABILITY

  2000cited by this paper
• Peptide and Protein Drug Analysis

  1999cited by this paper
• Instability, stabilization, and formulation of liquid protein pharmaceuticals.

  1999cited by this paper
• Application of a thermodynamic model to the prediction of phase separations in freeze-concentrated formulations for protein lyophilization.

  1999cited by this paper
• The Effect of Formulation Excipients on Protein Stability and Aerosol Performance of Spray-Dried Powders of a Recombinant Humanized Anti-IgE Monoclonal Antibody1

  1999cited by this paper
• Local water bridges and protein conformational stability

  1999cited by this paper
• Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying.

  1999cited by this paper
• Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid.

  1999cited by this paper
• Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions.

  1998cited by this paper
• Deterioration of lyophilized pharmaceutical proteins.

  1998cited by this paper
• Interleukin-1 Receptor (IL-1R) Liquid Formulation Development Using Differential Scanning Calorimetry

  1998cited by this paper
• Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone.

  1998cited by this paper
• Analysis of plasmid DNA from a pharmaceutical perspective.

  1998cited by this paper
• Spray Dried Powders and Powder Blends of Recombinant Human Deoxyribonuclease (rhDNase) for Aerosol Delivery

  1997cited by this paper
• The effect of ionic conditions on DNA helical repeat, effective diameter and free energy of supercoiling.

  1997cited by this paper
• Pharmaceutical processing with supercritical carbon dioxide.

  1997cited by this paper
• Development of a Freeze-Dried Albumin-Free Formulation of Recombinant Factor VIII SQ

  1997cited by this paper
• Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses.

  1997cited by this paper
• A case study and use of sedimentation equilibrium analytical ultracentrifugation as a tool for biopharmaceutical development

  1997cited by this paper
• Adsorption of recombinant human granulocyte colony stimulating factor (rhG-CSF) to polyvinyl chloride, polypropylene, and glass: effect of solvent additives.

  1996cited by this paper
• Thermal stability of low molecular weight urokinase during heat treatment. III. Effect of salts, sugars and Tween 80

  1996cited by this paper
• Catalytic metals, ascorbate and free radicals: combinations to avoid.

  1996cited by this paper
• Energetics of cyclodextrin-induced dissociation of insulin

  1996cited by this paper
• Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison.

  1996cited by this paper
• Storage stability of the solution formulation of sCD4 determined by DSC in comparison with two functional assays

  1996cited by this paper
• Effect of surfactants on the physical stability of recombinant human growth hormone.

  1995cited by this paper
• The adsorption of insulinotropin to polymeric sterilizing filters.

  1994cited by this paper
• Conformational and thermodynamic properties of supercoiled DNA.

  1994cited by this paper
• Mechanistic studies on depurination and apurinic site chain breakage in oligodeoxyribonucleotides.

  1994cited by this paper
• Increased thermal stability of proteins in the presence of amino acids.

  1994cited by this paper
• Lyophilization of biotechnology products.

  1994cited by this paper
• The generation of DNA single-strand breaks during the reduction of chromate by ascorbic acid and/or glutathione in vitro.

  1994cited by this paper
• Secondary structure characterization of microparticulate insulin powders.

  1994cited by this paper
• Stability and Characterization of Protein and Peptide Drugs

  1993cited by this paper
• Instability and decay of the primary structure of DNA

  1993cited by this paper
• The Effect of Salts on the Stability of β-Galactosidase in Aqueous Solution, as Related to the Water Mobility

  1993cited by this paper
• The application of size exclusion chromatography and computer simulation to study the thermodynamic and kinetic parameters for short-lived dissociable protein aggregates.

  1993cited by this paper
• Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407.

  1993cited by this paper
• The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.

  1993cited by this paper
• Differential scanning calorimetry of thermal unfolding of the methionine repressor protein (MetJ) from Escherichia coli.

  1992cited by this paper
• Mechanism of insulin aggregation and stabilization in agitated aqueous solutions

  1992cited by this paper
• Pharmaceutics of protein drugs.

  1992cited by this paper
• Comparative study of biosynthetic human growth hormone immunogenicity in growth hormone deficient children.

  1991cited by this paper
• Effect of Freezing on Aggregation of Human Growth Hormone

  1991cited by this paper
• Loss of Peptides and Proteins Upon Sterile Filtration Due to Adsorption to Membrane Filters

  1989cited by this paper
• Stability of Protein Pharmaceuticals

  1989cited by this paper
• Secondary structure changes of disulfide bridge-cleaved bovine serum albumin in solutions of urea, guanidine hydrochloride, and sodium dodecyl sulfate

  1988cited by this paper
• Secondary structural changes of non-reduced and reduced ribonuclease A in solutions of urea, guanidine hydrochloride and sodium dodecyl sulfate.

  1988cited by this paper
• Use of lyoprotectants in the freeze-drying of a model protein, ribonuclease A.

  1988cited by this paper
• Energy-structure correlations of plasmid DNA in different topological forms.

  1988cited by this paper
• Reassessment of the electronic circular dichroism criteria for random coil conformations of poly(L-lysine) and the implications for protein folding and denaturation studies.

  1988cited by this paper
• The thermodynamic stability of proteins.

  1987cited by this paper
• Chemical, Physical, and Biological Characterization of a Dimeric form of Biosynthetic Human Growth Hormone

  1987cited by this paper
• Thermodynamic stability of proteins in salt solutions: A comparison of the effectiveness of protein stabilizers

  1986cited by this paper
• Surface and Interfacial Aspects of Biomedical Polymers

  1985cited by this paper
• Pump-induced Insulin Aggregation: A Problem with the Biostator

  1985cited by this paper
• Aggregation of Insulin, Containing Surfactants, in Contact with Different Materials

  1985cited by this paper
• Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.

  1984cited by this paper
• Minimizing the aggregation of neutral insulin solutions.

  1983cited by this paper
• [28] Cleavage at aspartic acid

  1983cited by this paper
• Cleavage at aspartic acid.

  1983cited by this paper
• Stabilization of protein structure by sugars.

  1982cited by this paper
• The stabilization of proteins by sucrose.

  1981cited by this paper
• Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures.

  1981cited by this paper
• The photodecomposition of tryptophan peptides.

  1977cited by this paper
• Equilibrium adsorption of proteins.

  1970cited by this paper

• Antibody Oxidation and Impact of Formulation: A High-Throughput Screening Approach.

  2025cites this paper
• Regulatory Guidelines for the Analysis of Therapeutic Peptides and Proteins

  2025influential citation
• Determinants for arginine-mediated modulation of thermodynamic stability and conformational dynamics of horse cytochrome c

  2025cites this paper
• Formulation, sterilization, and clinical evaluation of microneedles for vaccine and biologic delivery: A review.

  2025cites this paper
• Rapid and high accuracy identification of culture medium by CNN of Raman spectra.

  2024cites this paper
• Identification of Surfactant Impact on a Monoclonal Antibody Characterization via HPLC-Separation Based and Biophysical Methods

  2024cites this paper
• Adsorption of monoclonal antibody fragments at the water–oil interface: A coarse-grained molecular dynamics study

  2024cites this paper
• Stability of Protein Pharmaceuticals: Recent Advances

  2024cites this paper
• Optimization of Methodologies to Study Freeze/Thaw Processes in Drug Substance Bottles

  2024cites this paper
• Fluorescence-Based Protein Stability Monitoring—A Review

  2024cites this paper
• Compaction Properties of Particulate Proteins in Binary Powder Mixtures with Common Excipients

  2023cites this paper
• Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review

  2023influential citation
• Bioconjugation Techniques for Enhancing Stability and Targeting Efficiency of Protein and Peptide Therapeutics.

  2023cites this paper
• Ranking mAb–excipient interactions in biologics formulations by NMR spectroscopy and computational approaches

  2023cites this paper
• Facile fabrication of nanofibrous ion-exchange chromatography membrane with aminated surface for highly efficient RNA separation and purification

  2022cites this paper
• Glycopeptide antibiotic drug stability in aqueous solution

  2022cites this paper
• Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery

  2022influential citation
• Stable Dried Catalase Particles Prepared by Electrospraying

  2022influential citation
• Síntesis en fase sólida de un neuropéptido cosmecéutico y su microencapsulación en un sistema liposomal

  2021cites this paper
• The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing

  2021cites this paper
• Polysorbate 80 Controls Morphology, Structure and Stability of Human Insulin Amyloid-Like Spherulites

  2021cites this paper
• The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics

  2021cites this paper
• Critical considerations in the formulation development of parenteral biologic drugs.

  2020cites this paper
• Compression of vectors for small interfering RNAs delivery: toward oral administration of siRNA lipoplexes in tablet form.

  2020cites this paper
• Excipients in freeze-dried biopharmaceuticals: contributions toward formulation stability and lyophilisation cycle optimisation.

  2020cites this paper
• Current Applications of Pharmaceutical Biotechnology

  2020cites this paper
• Insights on the Formulation of Recombinant Proteins.

  2019cites this paper
• Spectroscopy as Process Analytical Technology for Preparative Protein Purification

  2019influential citation
• Enzyme stabilization for biotechnological applications

  2019cites this paper
• Exploring the chemical space for freeze-drying excipients.

  2019cites this paper
• Etude et ingénierie de la N-glycosylation des protéines chez la microalgue verte chlamydomanas reinhardtii.

  2019cites this paper
• In-line Fourier-transform infrared spectroscopy as a versatile process analytical technology for preparative protein chromatography.

  2018cites this paper
• In vitro and in vivo characterization of an interleukin‐15 antagonist peptide by metabolic stability, 99mTc‐labeling, and biological activity assays

  2018cites this paper
• Rational Design of Liquid Formulations of Proteins.

  2018cites this paper
• Natural deep eutectic solvents as a storage medium for human interferon-α2: a green and improved strategy for room-temperature biologics

  2018cites this paper
• Basic Principles of Formulation for Biotherapeutics: Approaches to Alternative Drug Delivery

  2017cites this paper
• Concise Review: Considerations for the Formulation, Delivery and Administration Routes of Biopharmaceuticals

  2017cites this paper
• Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides.

  2017cites this paper
• Lack of a synergistic effect of arginine–glutamic acid on the physical stability of spray-dried bovine serum albumin

  2017cites this paper
• Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant

  2017cites this paper
• Role of Buffers in Protein Formulations.

  2017cites this paper
• Procédé pour purifier et quantifier la thrombine et ses polypeptides de dégradation

  2016cites this paper
• Control of Globular Protein Thermal Stability in Aqueous Formulations by the Positively Charged Amino Acid Excipients.

  2016cites this paper
• Controlling protein stability: Mechanisms revealed using formulations of arginine, glycine and guanidinium HCl with three globular proteins.

  2015cites this paper
• Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations

  2015cites this paper
• Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles.

  2015cites this paper
• Influência da tecnologia de purificação e estabilização na atividade biológica do microRNA

  2015influential citation
• Développement d’une protéine à libération prolongée, mise au point du procédé d’encapsulation sans solvant halogéné et optimisation du profil de libération.

  2015cites this paper
• Nanofibrous solid dosage form of living bacteria prepared by electrospinning

  2014cites this paper
• Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges

  2014cites this paper
• Stability, structure, and formulation of antibody fragments during bioprocessing

  2014cites this paper
• Protéines de liaison à l'antigène tnf-alpha

  2014cites this paper
• Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.

  2014cites this paper
• Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer

  2014cites this paper
• Understanding correlations between secondary relaxations and thermal behaviour of biologically relevant molecules

  2013cites this paper
• Developments and Challenges for mAb-Based Therapeutics

  2013cites this paper
• Preventing adsorption of immunoglobulin G to solid surfaces using poloxamer 407 eliminates artifactual stimulation of neutrophils.

  2013cites this paper
• Towards the understanding of complex fluids in pharmaceutical sciences

  2013cites this paper
• Detecting phase separation of freeze-dried binary amorphous systems using pair-wise distribution function and multivariate data analysis.

  2013cites this paper
• Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry.

  2013cites this paper
• A formulation method to improve the physical stability of macromolecular-based drug products

  2012cites this paper
• Formulation liquide contenant adalimumab et un tampon acetate

  2012cites this paper
• Biotherapeutic Formulation Factors Affecting Metal Leachables from Stainless Steel Studied by Design of Experiments

  2012cites this paper
• Analytical methods and formulation factors to enhance protein stability in solution

  2012cites this paper
• Complexes solubles non covalents de tériparatide contenant des polysaccharides et forme pharmaceutique de tériparatide pour administration orale

  2012cites this paper
• Overview of Drug Product Development

  2011cites this paper
• Environmental issues relating to the manufacture of antisense-based products of phamaceutical biotechnology.

  2011cites this paper
• Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.

  2011cites this paper
• Impact of product-related factors on immunogenicity of biotherapeutics.

  2011cites this paper
• Adsorption of proteins at the oil/water interface--observation of protein adsorption by interfacial shear stress measurements.

  2010cites this paper
• Role of Posttranslational Modifications in Amyloid Formation

  2010cites this paper
• Stability Assessment and Formulation Characterization

  2010cites this paper
• Application note 28-9870-37 AA MicroCal TM label-free interaction analysis Applications of differential scanning calorimetry in the development of liquid formulations for protein biopharmaceuticals 1

  2010cites this paper
• Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha mutein.

  2010cites this paper
• Alginate-loaded liposomes can protect encapsulated alkaline phosphatase functionality when exposed to gastric pH.

  2010cites this paper
• PEG-modified biopharmaceuticals

  2009cites this paper
• Recent trends in stabilising peptides and proteins in pharmaceutical formulation – considerations in the choice of excipients

  2009influential citation
• PEG-modified biopharmaceuticals.

  2009cites this paper
• Stability Improvement of a Therapeutic Protein by Reducing Agent Pretreatment

  2008cites this paper
• Impact of filling processes on protein solutions

  2008cites this paper
• High throughput screening of protein formulation stability: practical considerations.

  2007cites this paper
• Bulk Freeze – Thawing of Macromolecules Effects of Cryoconcentration on Their Formulation and Stability

  2007cites this paper
• Kinetics of Insulin Adsorption at the Oil–Water Interface and Diffusion Properties of Adsorbed Layers Monitored Using Fluorescence Correlation Spectroscopy

  2006cites this paper
• Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.

  2005cites this paper
• Probing structural changes of proteins incorporated into water-in-oil emulsions.

  2004cites this paper
• Methode de stabilisation d'anticorps et preparation d'anticorps de type solution stabilisee

  2004cites this paper
• In vitro release of insulin aspart incorporated into water-in-oil emulsions

  2004cites this paper
• Verfahren zur stabilisierung von antikörpern und stabilisierte antikörperzubereitung vom lösungstyp

  2004cites this paper
• Integrity of crystalline lysozyme exceeds that of a spray-dried form.

  2002cites this paper
• Protein release profiles and morphology of biodegradable microcapsules containing an oily core.

  2001cites this paper